Frontiers in Oncology-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2289815, encodeId=a3b4228981559, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：写的case，肿瘤病理分化特殊类型 8.26投稿，12.04号2个审稿小修修回，12.10接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuDC8KzEKjPbtibiazcGV6hymc4Fp1dg4xRJOicG9garJDkw2LxwsXJcB68P5Jrs2lTcVA2KMUpMAK3Z/0, createdBy=a5c62067526, createdName=ms4085869792928798, createdTime=Thu Nov 20 15:16:13 CST 2025, time=2025-11-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2266079, encodeId=9fba22660e938, content=请问有没有遇到版面费支付完后在invoice可以看到已支付，但是在submission还是显示unpaid，一般付款后几天能显示已支付呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=67dd2027216, createdName=1e227a5em69(暂无匿称), createdTime=Wed May 21 21:14:22 CST 2025, time=2025-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2284113, encodeId=8b86228411378, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：按照审稿人给的修改意见认真修改后很快就被录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9fd6560658, createdName=ms6000000046559377, createdTime=Thu Oct 09 12:13:43 CST 2025, time=2025-10-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2262558, encodeId=fc282262558ae, content=JCR Q2，中科院医学大类3区，覆盖癌症生物学、免疫治疗、外科手术、基因组学等方向，尤其重视基础与临床研究的结合。期刊对国人友好，2022-2023年国人发文占比超56%，位居第一。 整体较快，平均1-3个月完成审稿。 文章类型：以Article（69.88%）和Review（24.69%）为主，病例报告需严格遵循CARE指南并获取患者知情同意。 格式要求：英语撰写，重复率≤10%，参考文献≥25条（近5年占比50%+），图表分辨率≥300dpi。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms6000002977722155, createdTime=Sun Apr 27 23:19:55 CST 2025, time=2025-04-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2260115, encodeId=d34e2260115b6, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤学 经验分享：2024年10月底投稿，外审大概2个月，修改一次后在2025年2月底就接收，2025年3月初发表，投稿的是一篇证据总结，我觉得还挺快的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d15e4714042, createdName=1442866843, createdTime=Sat Apr 12 09:46:11 CST 2025, time=2025-04-12, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2251961, encodeId=c36622519616a, content=偏重的研究方向：肿瘤 经验分享：第二次投了，妇科肿瘤方向，17天了仍是Editorial Assignment状态，副编辑仍未分配，朋友们你们的也这么慢吗？是杂志整体变慢了吗？我记得第一次的时候蛮快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c00d8129740, createdName=ms4000001757914888, createdTime=Fri Feb 14 19:13:46 CST 2025, time=2025-02-14, status=1, ipAttribution=辽宁), GetPortalCommentsPageByObjectIdResponse(id=2255948, encodeId=5ac5225594847, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：外科;结直肠癌 经验分享：结直肠癌外科手术方面的小文章，编辑速度很快，2个小修，2周修回，再1周接收。比较担心被预警。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/4oGJanAwYP71kBMib4MbsUH6DlDZThuRKQkJ1ibJkzuurhSJZ4zcxZPBQYr2OLZdl3dkfq351dJ9kWv5pCZmjLPg/132, createdBy=c2c22368859, createdName=prosperli, createdTime=Thu Mar 13 19:16:27 CST 2025, time=2025-03-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2252015, encodeId=9c2322520150a, content=偏重的研究方向：肿瘤 经验分享：投了一篇Meta，顺利接收，时间线如下： Received date: 16 Jan 2025 Editorial assignment start date: 16 Jan 2025 Independent review start date: 18 Jan 2025 Interactive review activated date: 26 Jan 2025 Review finalized date: 10 Feb 2025 Final validation date: 13 Feb 2025 感谢大家的经验分享，受益良多，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DSKSsTZWSAHzbu47LXNPxMa56rEEsmGbA6TZOLicSdqXhIJT8tce14ZrGYB0p0LPAKzZyVUUstj63e7UzvYT9ew/132, createdBy=1dff2428106, createdName=要没时间了, createdTime=Sat Feb 15 09:57:36 CST 2025, time=2025-02-15, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2247280, encodeId=86c0224e2800b, content=多久才能pubmed检索啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20b65452622, createdName=ms8000000124135786, createdTime=Thu Jan 09 14:13:27 CST 2025, time=2025-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2247822, encodeId=79ad224e82258, content=投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：审稿周期太长了，将近11个月，胃癌蛋白组学的分层模型，刚开始邀请2个审稿人，结果有一个给了provoke,再次邀请花费了将近3个月，最后1 1月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Mon Jan 13 01:43:01 CST 2025, time=2025-01-13, status=1, ipAttribution=山西省)]

2025-11-20 ms4085869792928798 来自浙江省

审稿速度:3.0 | 投稿命中率:95.0
偏重的研究方向：肿瘤
经验分享：写的case，肿瘤病理分化特殊类型 8.26投稿，12.04号2个审稿小修修回，12.10接受。

41 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2289815, encodeId=a3b4228981559, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：写的case，肿瘤病理分化特殊类型 8.26投稿，12.04号2个审稿小修修回，12.10接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuDC8KzEKjPbtibiazcGV6hymc4Fp1dg4xRJOicG9garJDkw2LxwsXJcB68P5Jrs2lTcVA2KMUpMAK3Z/0, createdBy=a5c62067526, createdName=ms4085869792928798, createdTime=Thu Nov 20 15:16:13 CST 2025, time=2025-11-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2266079, encodeId=9fba22660e938, content=请问有没有遇到版面费支付完后在invoice可以看到已支付，但是在submission还是显示unpaid，一般付款后几天能显示已支付呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=67dd2027216, createdName=1e227a5em69(暂无匿称), createdTime=Wed May 21 21:14:22 CST 2025, time=2025-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2284113, encodeId=8b86228411378, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：按照审稿人给的修改意见认真修改后很快就被录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9fd6560658, createdName=ms6000000046559377, createdTime=Thu Oct 09 12:13:43 CST 2025, time=2025-10-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2262558, encodeId=fc282262558ae, content=JCR Q2，中科院医学大类3区，覆盖癌症生物学、免疫治疗、外科手术、基因组学等方向，尤其重视基础与临床研究的结合。期刊对国人友好，2022-2023年国人发文占比超56%，位居第一。 整体较快，平均1-3个月完成审稿。 文章类型：以Article（69.88%）和Review（24.69%）为主，病例报告需严格遵循CARE指南并获取患者知情同意。 格式要求：英语撰写，重复率≤10%，参考文献≥25条（近5年占比50%+），图表分辨率≥300dpi。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms6000002977722155, createdTime=Sun Apr 27 23:19:55 CST 2025, time=2025-04-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2260115, encodeId=d34e2260115b6, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤学 经验分享：2024年10月底投稿，外审大概2个月，修改一次后在2025年2月底就接收，2025年3月初发表，投稿的是一篇证据总结，我觉得还挺快的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d15e4714042, createdName=1442866843, createdTime=Sat Apr 12 09:46:11 CST 2025, time=2025-04-12, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2251961, encodeId=c36622519616a, content=偏重的研究方向：肿瘤 经验分享：第二次投了，妇科肿瘤方向，17天了仍是Editorial Assignment状态，副编辑仍未分配，朋友们你们的也这么慢吗？是杂志整体变慢了吗？我记得第一次的时候蛮快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c00d8129740, createdName=ms4000001757914888, createdTime=Fri Feb 14 19:13:46 CST 2025, time=2025-02-14, status=1, ipAttribution=辽宁), GetPortalCommentsPageByObjectIdResponse(id=2255948, encodeId=5ac5225594847, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：外科;结直肠癌 经验分享：结直肠癌外科手术方面的小文章，编辑速度很快，2个小修，2周修回，再1周接收。比较担心被预警。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/4oGJanAwYP71kBMib4MbsUH6DlDZThuRKQkJ1ibJkzuurhSJZ4zcxZPBQYr2OLZdl3dkfq351dJ9kWv5pCZmjLPg/132, createdBy=c2c22368859, createdName=prosperli, createdTime=Thu Mar 13 19:16:27 CST 2025, time=2025-03-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2252015, encodeId=9c2322520150a, content=偏重的研究方向：肿瘤 经验分享：投了一篇Meta，顺利接收，时间线如下： Received date: 16 Jan 2025 Editorial assignment start date: 16 Jan 2025 Independent review start date: 18 Jan 2025 Interactive review activated date: 26 Jan 2025 Review finalized date: 10 Feb 2025 Final validation date: 13 Feb 2025 感谢大家的经验分享，受益良多，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DSKSsTZWSAHzbu47LXNPxMa56rEEsmGbA6TZOLicSdqXhIJT8tce14ZrGYB0p0LPAKzZyVUUstj63e7UzvYT9ew/132, createdBy=1dff2428106, createdName=要没时间了, createdTime=Sat Feb 15 09:57:36 CST 2025, time=2025-02-15, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2247280, encodeId=86c0224e2800b, content=多久才能pubmed检索啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20b65452622, createdName=ms8000000124135786, createdTime=Thu Jan 09 14:13:27 CST 2025, time=2025-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2247822, encodeId=79ad224e82258, content=投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：审稿周期太长了，将近11个月，胃癌蛋白组学的分层模型，刚开始邀请2个审稿人，结果有一个给了provoke,再次邀请花费了将近3个月，最后1 1月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Mon Jan 13 01:43:01 CST 2025, time=2025-01-13, status=1, ipAttribution=山西省)]

2025-05-21 1e227a5em69(暂无匿称)

请问有没有遇到版面费支付完后在invoice可以看到已支付，但是在submission还是显示unpaid，一般付款后几天能显示已支付呢

108 4 举报

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2289815, encodeId=a3b4228981559, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：写的case，肿瘤病理分化特殊类型 8.26投稿，12.04号2个审稿小修修回，12.10接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuDC8KzEKjPbtibiazcGV6hymc4Fp1dg4xRJOicG9garJDkw2LxwsXJcB68P5Jrs2lTcVA2KMUpMAK3Z/0, createdBy=a5c62067526, createdName=ms4085869792928798, createdTime=Thu Nov 20 15:16:13 CST 2025, time=2025-11-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2266079, encodeId=9fba22660e938, content=请问有没有遇到版面费支付完后在invoice可以看到已支付，但是在submission还是显示unpaid，一般付款后几天能显示已支付呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=67dd2027216, createdName=1e227a5em69(暂无匿称), createdTime=Wed May 21 21:14:22 CST 2025, time=2025-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2284113, encodeId=8b86228411378, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：按照审稿人给的修改意见认真修改后很快就被录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9fd6560658, createdName=ms6000000046559377, createdTime=Thu Oct 09 12:13:43 CST 2025, time=2025-10-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2262558, encodeId=fc282262558ae, content=JCR Q2，中科院医学大类3区，覆盖癌症生物学、免疫治疗、外科手术、基因组学等方向，尤其重视基础与临床研究的结合。期刊对国人友好，2022-2023年国人发文占比超56%，位居第一。 整体较快，平均1-3个月完成审稿。 文章类型：以Article（69.88%）和Review（24.69%）为主，病例报告需严格遵循CARE指南并获取患者知情同意。 格式要求：英语撰写，重复率≤10%，参考文献≥25条（近5年占比50%+），图表分辨率≥300dpi。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms6000002977722155, createdTime=Sun Apr 27 23:19:55 CST 2025, time=2025-04-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2260115, encodeId=d34e2260115b6, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤学 经验分享：2024年10月底投稿，外审大概2个月，修改一次后在2025年2月底就接收，2025年3月初发表，投稿的是一篇证据总结，我觉得还挺快的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d15e4714042, createdName=1442866843, createdTime=Sat Apr 12 09:46:11 CST 2025, time=2025-04-12, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2251961, encodeId=c36622519616a, content=偏重的研究方向：肿瘤 经验分享：第二次投了，妇科肿瘤方向，17天了仍是Editorial Assignment状态，副编辑仍未分配，朋友们你们的也这么慢吗？是杂志整体变慢了吗？我记得第一次的时候蛮快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c00d8129740, createdName=ms4000001757914888, createdTime=Fri Feb 14 19:13:46 CST 2025, time=2025-02-14, status=1, ipAttribution=辽宁), GetPortalCommentsPageByObjectIdResponse(id=2255948, encodeId=5ac5225594847, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：外科;结直肠癌 经验分享：结直肠癌外科手术方面的小文章，编辑速度很快，2个小修，2周修回，再1周接收。比较担心被预警。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/4oGJanAwYP71kBMib4MbsUH6DlDZThuRKQkJ1ibJkzuurhSJZ4zcxZPBQYr2OLZdl3dkfq351dJ9kWv5pCZmjLPg/132, createdBy=c2c22368859, createdName=prosperli, createdTime=Thu Mar 13 19:16:27 CST 2025, time=2025-03-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2252015, encodeId=9c2322520150a, content=偏重的研究方向：肿瘤 经验分享：投了一篇Meta，顺利接收，时间线如下： Received date: 16 Jan 2025 Editorial assignment start date: 16 Jan 2025 Independent review start date: 18 Jan 2025 Interactive review activated date: 26 Jan 2025 Review finalized date: 10 Feb 2025 Final validation date: 13 Feb 2025 感谢大家的经验分享，受益良多，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DSKSsTZWSAHzbu47LXNPxMa56rEEsmGbA6TZOLicSdqXhIJT8tce14ZrGYB0p0LPAKzZyVUUstj63e7UzvYT9ew/132, createdBy=1dff2428106, createdName=要没时间了, createdTime=Sat Feb 15 09:57:36 CST 2025, time=2025-02-15, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2247280, encodeId=86c0224e2800b, content=多久才能pubmed检索啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20b65452622, createdName=ms8000000124135786, createdTime=Thu Jan 09 14:13:27 CST 2025, time=2025-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2247822, encodeId=79ad224e82258, content=投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：审稿周期太长了，将近11个月，胃癌蛋白组学的分层模型，刚开始邀请2个审稿人，结果有一个给了provoke,再次邀请花费了将近3个月，最后1 1月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Mon Jan 13 01:43:01 CST 2025, time=2025-01-13, status=1, ipAttribution=山西省)]

2025-10-09 ms6000000046559377 来自四川省

审稿速度:1.0 | 投稿命中率:75.0
经验分享：按照审稿人给的修改意见认真修改后很快就被录用

52 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2289815, encodeId=a3b4228981559, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：写的case，肿瘤病理分化特殊类型 8.26投稿，12.04号2个审稿小修修回，12.10接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuDC8KzEKjPbtibiazcGV6hymc4Fp1dg4xRJOicG9garJDkw2LxwsXJcB68P5Jrs2lTcVA2KMUpMAK3Z/0, createdBy=a5c62067526, createdName=ms4085869792928798, createdTime=Thu Nov 20 15:16:13 CST 2025, time=2025-11-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2266079, encodeId=9fba22660e938, content=请问有没有遇到版面费支付完后在invoice可以看到已支付，但是在submission还是显示unpaid，一般付款后几天能显示已支付呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=67dd2027216, createdName=1e227a5em69(暂无匿称), createdTime=Wed May 21 21:14:22 CST 2025, time=2025-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2284113, encodeId=8b86228411378, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：按照审稿人给的修改意见认真修改后很快就被录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9fd6560658, createdName=ms6000000046559377, createdTime=Thu Oct 09 12:13:43 CST 2025, time=2025-10-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2262558, encodeId=fc282262558ae, content=JCR Q2，中科院医学大类3区，覆盖癌症生物学、免疫治疗、外科手术、基因组学等方向，尤其重视基础与临床研究的结合。期刊对国人友好，2022-2023年国人发文占比超56%，位居第一。 整体较快，平均1-3个月完成审稿。 文章类型：以Article（69.88%）和Review（24.69%）为主，病例报告需严格遵循CARE指南并获取患者知情同意。 格式要求：英语撰写，重复率≤10%，参考文献≥25条（近5年占比50%+），图表分辨率≥300dpi。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms6000002977722155, createdTime=Sun Apr 27 23:19:55 CST 2025, time=2025-04-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2260115, encodeId=d34e2260115b6, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤学 经验分享：2024年10月底投稿，外审大概2个月，修改一次后在2025年2月底就接收，2025年3月初发表，投稿的是一篇证据总结，我觉得还挺快的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d15e4714042, createdName=1442866843, createdTime=Sat Apr 12 09:46:11 CST 2025, time=2025-04-12, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2251961, encodeId=c36622519616a, content=偏重的研究方向：肿瘤 经验分享：第二次投了，妇科肿瘤方向，17天了仍是Editorial Assignment状态，副编辑仍未分配，朋友们你们的也这么慢吗？是杂志整体变慢了吗？我记得第一次的时候蛮快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c00d8129740, createdName=ms4000001757914888, createdTime=Fri Feb 14 19:13:46 CST 2025, time=2025-02-14, status=1, ipAttribution=辽宁), GetPortalCommentsPageByObjectIdResponse(id=2255948, encodeId=5ac5225594847, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：外科;结直肠癌 经验分享：结直肠癌外科手术方面的小文章，编辑速度很快，2个小修，2周修回，再1周接收。比较担心被预警。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/4oGJanAwYP71kBMib4MbsUH6DlDZThuRKQkJ1ibJkzuurhSJZ4zcxZPBQYr2OLZdl3dkfq351dJ9kWv5pCZmjLPg/132, createdBy=c2c22368859, createdName=prosperli, createdTime=Thu Mar 13 19:16:27 CST 2025, time=2025-03-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2252015, encodeId=9c2322520150a, content=偏重的研究方向：肿瘤 经验分享：投了一篇Meta，顺利接收，时间线如下： Received date: 16 Jan 2025 Editorial assignment start date: 16 Jan 2025 Independent review start date: 18 Jan 2025 Interactive review activated date: 26 Jan 2025 Review finalized date: 10 Feb 2025 Final validation date: 13 Feb 2025 感谢大家的经验分享，受益良多，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DSKSsTZWSAHzbu47LXNPxMa56rEEsmGbA6TZOLicSdqXhIJT8tce14ZrGYB0p0LPAKzZyVUUstj63e7UzvYT9ew/132, createdBy=1dff2428106, createdName=要没时间了, createdTime=Sat Feb 15 09:57:36 CST 2025, time=2025-02-15, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2247280, encodeId=86c0224e2800b, content=多久才能pubmed检索啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20b65452622, createdName=ms8000000124135786, createdTime=Thu Jan 09 14:13:27 CST 2025, time=2025-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2247822, encodeId=79ad224e82258, content=投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：审稿周期太长了，将近11个月，胃癌蛋白组学的分层模型，刚开始邀请2个审稿人，结果有一个给了provoke,再次邀请花费了将近3个月，最后1 1月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Mon Jan 13 01:43:01 CST 2025, time=2025-01-13, status=1, ipAttribution=山西省)]

2025-04-27 ms6000002977722155 来自上海

JCR Q2，中科院医学大类3区，覆盖癌症生物学、免疫治疗、外科手术、基因组学等方向，尤其重视基础与临床研究的结合。期刊对国人友好，2022-2023年国人发文占比超56%，位居第一。
整体较快，平均1-3个月完成审稿。
文章类型：以Article（69.88%）和Review（24.69%）为主，病例报告需严格遵循CARE指南并获取患者知情同意。
格式要求：英语撰写，重复率≤10%，参考文献≥25条（近5年占比50%+），图表分辨率≥300dpi。

113 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2289815, encodeId=a3b4228981559, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：写的case，肿瘤病理分化特殊类型 8.26投稿，12.04号2个审稿小修修回，12.10接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuDC8KzEKjPbtibiazcGV6hymc4Fp1dg4xRJOicG9garJDkw2LxwsXJcB68P5Jrs2lTcVA2KMUpMAK3Z/0, createdBy=a5c62067526, createdName=ms4085869792928798, createdTime=Thu Nov 20 15:16:13 CST 2025, time=2025-11-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2266079, encodeId=9fba22660e938, content=请问有没有遇到版面费支付完后在invoice可以看到已支付，但是在submission还是显示unpaid，一般付款后几天能显示已支付呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=67dd2027216, createdName=1e227a5em69(暂无匿称), createdTime=Wed May 21 21:14:22 CST 2025, time=2025-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2284113, encodeId=8b86228411378, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：按照审稿人给的修改意见认真修改后很快就被录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9fd6560658, createdName=ms6000000046559377, createdTime=Thu Oct 09 12:13:43 CST 2025, time=2025-10-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2262558, encodeId=fc282262558ae, content=JCR Q2，中科院医学大类3区，覆盖癌症生物学、免疫治疗、外科手术、基因组学等方向，尤其重视基础与临床研究的结合。期刊对国人友好，2022-2023年国人发文占比超56%，位居第一。 整体较快，平均1-3个月完成审稿。 文章类型：以Article（69.88%）和Review（24.69%）为主，病例报告需严格遵循CARE指南并获取患者知情同意。 格式要求：英语撰写，重复率≤10%，参考文献≥25条（近5年占比50%+），图表分辨率≥300dpi。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms6000002977722155, createdTime=Sun Apr 27 23:19:55 CST 2025, time=2025-04-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2260115, encodeId=d34e2260115b6, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤学 经验分享：2024年10月底投稿，外审大概2个月，修改一次后在2025年2月底就接收，2025年3月初发表，投稿的是一篇证据总结，我觉得还挺快的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d15e4714042, createdName=1442866843, createdTime=Sat Apr 12 09:46:11 CST 2025, time=2025-04-12, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2251961, encodeId=c36622519616a, content=偏重的研究方向：肿瘤 经验分享：第二次投了，妇科肿瘤方向，17天了仍是Editorial Assignment状态，副编辑仍未分配，朋友们你们的也这么慢吗？是杂志整体变慢了吗？我记得第一次的时候蛮快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c00d8129740, createdName=ms4000001757914888, createdTime=Fri Feb 14 19:13:46 CST 2025, time=2025-02-14, status=1, ipAttribution=辽宁), GetPortalCommentsPageByObjectIdResponse(id=2255948, encodeId=5ac5225594847, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：外科;结直肠癌 经验分享：结直肠癌外科手术方面的小文章，编辑速度很快，2个小修，2周修回，再1周接收。比较担心被预警。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/4oGJanAwYP71kBMib4MbsUH6DlDZThuRKQkJ1ibJkzuurhSJZ4zcxZPBQYr2OLZdl3dkfq351dJ9kWv5pCZmjLPg/132, createdBy=c2c22368859, createdName=prosperli, createdTime=Thu Mar 13 19:16:27 CST 2025, time=2025-03-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2252015, encodeId=9c2322520150a, content=偏重的研究方向：肿瘤 经验分享：投了一篇Meta，顺利接收，时间线如下： Received date: 16 Jan 2025 Editorial assignment start date: 16 Jan 2025 Independent review start date: 18 Jan 2025 Interactive review activated date: 26 Jan 2025 Review finalized date: 10 Feb 2025 Final validation date: 13 Feb 2025 感谢大家的经验分享，受益良多，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DSKSsTZWSAHzbu47LXNPxMa56rEEsmGbA6TZOLicSdqXhIJT8tce14ZrGYB0p0LPAKzZyVUUstj63e7UzvYT9ew/132, createdBy=1dff2428106, createdName=要没时间了, createdTime=Sat Feb 15 09:57:36 CST 2025, time=2025-02-15, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2247280, encodeId=86c0224e2800b, content=多久才能pubmed检索啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20b65452622, createdName=ms8000000124135786, createdTime=Thu Jan 09 14:13:27 CST 2025, time=2025-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2247822, encodeId=79ad224e82258, content=投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：审稿周期太长了，将近11个月，胃癌蛋白组学的分层模型，刚开始邀请2个审稿人，结果有一个给了provoke,再次邀请花费了将近3个月，最后1 1月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Mon Jan 13 01:43:01 CST 2025, time=2025-01-13, status=1, ipAttribution=山西省)]

2025-04-12 1442866843 来自湖南省

审稿速度:6.0 | 投稿命中率:75.0
偏重的研究方向：肿瘤学
经验分享：2024年10月底投稿，外审大概2个月，修改一次后在2025年2月底就接收，2025年3月初发表，投稿的是一篇证据总结，我觉得还挺快的。

109 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2289815, encodeId=a3b4228981559, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：写的case，肿瘤病理分化特殊类型 8.26投稿，12.04号2个审稿小修修回，12.10接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuDC8KzEKjPbtibiazcGV6hymc4Fp1dg4xRJOicG9garJDkw2LxwsXJcB68P5Jrs2lTcVA2KMUpMAK3Z/0, createdBy=a5c62067526, createdName=ms4085869792928798, createdTime=Thu Nov 20 15:16:13 CST 2025, time=2025-11-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2266079, encodeId=9fba22660e938, content=请问有没有遇到版面费支付完后在invoice可以看到已支付，但是在submission还是显示unpaid，一般付款后几天能显示已支付呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=67dd2027216, createdName=1e227a5em69(暂无匿称), createdTime=Wed May 21 21:14:22 CST 2025, time=2025-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2284113, encodeId=8b86228411378, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：按照审稿人给的修改意见认真修改后很快就被录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9fd6560658, createdName=ms6000000046559377, createdTime=Thu Oct 09 12:13:43 CST 2025, time=2025-10-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2262558, encodeId=fc282262558ae, content=JCR Q2，中科院医学大类3区，覆盖癌症生物学、免疫治疗、外科手术、基因组学等方向，尤其重视基础与临床研究的结合。期刊对国人友好，2022-2023年国人发文占比超56%，位居第一。 整体较快，平均1-3个月完成审稿。 文章类型：以Article（69.88%）和Review（24.69%）为主，病例报告需严格遵循CARE指南并获取患者知情同意。 格式要求：英语撰写，重复率≤10%，参考文献≥25条（近5年占比50%+），图表分辨率≥300dpi。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms6000002977722155, createdTime=Sun Apr 27 23:19:55 CST 2025, time=2025-04-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2260115, encodeId=d34e2260115b6, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤学 经验分享：2024年10月底投稿，外审大概2个月，修改一次后在2025年2月底就接收，2025年3月初发表，投稿的是一篇证据总结，我觉得还挺快的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d15e4714042, createdName=1442866843, createdTime=Sat Apr 12 09:46:11 CST 2025, time=2025-04-12, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2251961, encodeId=c36622519616a, content=偏重的研究方向：肿瘤 经验分享：第二次投了，妇科肿瘤方向，17天了仍是Editorial Assignment状态，副编辑仍未分配，朋友们你们的也这么慢吗？是杂志整体变慢了吗？我记得第一次的时候蛮快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c00d8129740, createdName=ms4000001757914888, createdTime=Fri Feb 14 19:13:46 CST 2025, time=2025-02-14, status=1, ipAttribution=辽宁), GetPortalCommentsPageByObjectIdResponse(id=2255948, encodeId=5ac5225594847, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：外科;结直肠癌 经验分享：结直肠癌外科手术方面的小文章，编辑速度很快，2个小修，2周修回，再1周接收。比较担心被预警。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/4oGJanAwYP71kBMib4MbsUH6DlDZThuRKQkJ1ibJkzuurhSJZ4zcxZPBQYr2OLZdl3dkfq351dJ9kWv5pCZmjLPg/132, createdBy=c2c22368859, createdName=prosperli, createdTime=Thu Mar 13 19:16:27 CST 2025, time=2025-03-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2252015, encodeId=9c2322520150a, content=偏重的研究方向：肿瘤 经验分享：投了一篇Meta，顺利接收，时间线如下： Received date: 16 Jan 2025 Editorial assignment start date: 16 Jan 2025 Independent review start date: 18 Jan 2025 Interactive review activated date: 26 Jan 2025 Review finalized date: 10 Feb 2025 Final validation date: 13 Feb 2025 感谢大家的经验分享，受益良多，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DSKSsTZWSAHzbu47LXNPxMa56rEEsmGbA6TZOLicSdqXhIJT8tce14ZrGYB0p0LPAKzZyVUUstj63e7UzvYT9ew/132, createdBy=1dff2428106, createdName=要没时间了, createdTime=Sat Feb 15 09:57:36 CST 2025, time=2025-02-15, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2247280, encodeId=86c0224e2800b, content=多久才能pubmed检索啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20b65452622, createdName=ms8000000124135786, createdTime=Thu Jan 09 14:13:27 CST 2025, time=2025-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2247822, encodeId=79ad224e82258, content=投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：审稿周期太长了，将近11个月，胃癌蛋白组学的分层模型，刚开始邀请2个审稿人，结果有一个给了provoke,再次邀请花费了将近3个月，最后1 1月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Mon Jan 13 01:43:01 CST 2025, time=2025-01-13, status=1, ipAttribution=山西省)]

2025-02-14 ms4000001757914888 来自辽宁

偏重的研究方向：肿瘤
经验分享：第二次投了，妇科肿瘤方向，17天了仍是Editorial Assignment状态，副编辑仍未分配，朋友们你们的也这么慢吗？是杂志整体变慢了吗？我记得第一次的时候蛮快的

161 4 举报

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2289815, encodeId=a3b4228981559, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：写的case，肿瘤病理分化特殊类型 8.26投稿，12.04号2个审稿小修修回，12.10接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuDC8KzEKjPbtibiazcGV6hymc4Fp1dg4xRJOicG9garJDkw2LxwsXJcB68P5Jrs2lTcVA2KMUpMAK3Z/0, createdBy=a5c62067526, createdName=ms4085869792928798, createdTime=Thu Nov 20 15:16:13 CST 2025, time=2025-11-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2266079, encodeId=9fba22660e938, content=请问有没有遇到版面费支付完后在invoice可以看到已支付，但是在submission还是显示unpaid，一般付款后几天能显示已支付呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=67dd2027216, createdName=1e227a5em69(暂无匿称), createdTime=Wed May 21 21:14:22 CST 2025, time=2025-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2284113, encodeId=8b86228411378, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：按照审稿人给的修改意见认真修改后很快就被录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9fd6560658, createdName=ms6000000046559377, createdTime=Thu Oct 09 12:13:43 CST 2025, time=2025-10-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2262558, encodeId=fc282262558ae, content=JCR Q2，中科院医学大类3区，覆盖癌症生物学、免疫治疗、外科手术、基因组学等方向，尤其重视基础与临床研究的结合。期刊对国人友好，2022-2023年国人发文占比超56%，位居第一。 整体较快，平均1-3个月完成审稿。 文章类型：以Article（69.88%）和Review（24.69%）为主，病例报告需严格遵循CARE指南并获取患者知情同意。 格式要求：英语撰写，重复率≤10%，参考文献≥25条（近5年占比50%+），图表分辨率≥300dpi。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms6000002977722155, createdTime=Sun Apr 27 23:19:55 CST 2025, time=2025-04-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2260115, encodeId=d34e2260115b6, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤学 经验分享：2024年10月底投稿，外审大概2个月，修改一次后在2025年2月底就接收，2025年3月初发表，投稿的是一篇证据总结，我觉得还挺快的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d15e4714042, createdName=1442866843, createdTime=Sat Apr 12 09:46:11 CST 2025, time=2025-04-12, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2251961, encodeId=c36622519616a, content=偏重的研究方向：肿瘤 经验分享：第二次投了，妇科肿瘤方向，17天了仍是Editorial Assignment状态，副编辑仍未分配，朋友们你们的也这么慢吗？是杂志整体变慢了吗？我记得第一次的时候蛮快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c00d8129740, createdName=ms4000001757914888, createdTime=Fri Feb 14 19:13:46 CST 2025, time=2025-02-14, status=1, ipAttribution=辽宁), GetPortalCommentsPageByObjectIdResponse(id=2255948, encodeId=5ac5225594847, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：外科;结直肠癌 经验分享：结直肠癌外科手术方面的小文章，编辑速度很快，2个小修，2周修回，再1周接收。比较担心被预警。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/4oGJanAwYP71kBMib4MbsUH6DlDZThuRKQkJ1ibJkzuurhSJZ4zcxZPBQYr2OLZdl3dkfq351dJ9kWv5pCZmjLPg/132, createdBy=c2c22368859, createdName=prosperli, createdTime=Thu Mar 13 19:16:27 CST 2025, time=2025-03-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2252015, encodeId=9c2322520150a, content=偏重的研究方向：肿瘤 经验分享：投了一篇Meta，顺利接收，时间线如下： Received date: 16 Jan 2025 Editorial assignment start date: 16 Jan 2025 Independent review start date: 18 Jan 2025 Interactive review activated date: 26 Jan 2025 Review finalized date: 10 Feb 2025 Final validation date: 13 Feb 2025 感谢大家的经验分享，受益良多，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DSKSsTZWSAHzbu47LXNPxMa56rEEsmGbA6TZOLicSdqXhIJT8tce14ZrGYB0p0LPAKzZyVUUstj63e7UzvYT9ew/132, createdBy=1dff2428106, createdName=要没时间了, createdTime=Sat Feb 15 09:57:36 CST 2025, time=2025-02-15, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2247280, encodeId=86c0224e2800b, content=多久才能pubmed检索啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20b65452622, createdName=ms8000000124135786, createdTime=Thu Jan 09 14:13:27 CST 2025, time=2025-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2247822, encodeId=79ad224e82258, content=投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：审稿周期太长了，将近11个月，胃癌蛋白组学的分层模型，刚开始邀请2个审稿人，结果有一个给了provoke,再次邀请花费了将近3个月，最后1 1月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Mon Jan 13 01:43:01 CST 2025, time=2025-01-13, status=1, ipAttribution=山西省)]

2025-03-13 prosperli 来自广东省

审稿速度:2.0 | 投稿命中率:75.0
偏重的研究方向：外科;结直肠癌
经验分享：结直肠癌外科手术方面的小文章，编辑速度很快，2个小修，2周修回，再1周接收。比较担心被预警。

127 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2289815, encodeId=a3b4228981559, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：写的case，肿瘤病理分化特殊类型 8.26投稿，12.04号2个审稿小修修回，12.10接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuDC8KzEKjPbtibiazcGV6hymc4Fp1dg4xRJOicG9garJDkw2LxwsXJcB68P5Jrs2lTcVA2KMUpMAK3Z/0, createdBy=a5c62067526, createdName=ms4085869792928798, createdTime=Thu Nov 20 15:16:13 CST 2025, time=2025-11-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2266079, encodeId=9fba22660e938, content=请问有没有遇到版面费支付完后在invoice可以看到已支付，但是在submission还是显示unpaid，一般付款后几天能显示已支付呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=67dd2027216, createdName=1e227a5em69(暂无匿称), createdTime=Wed May 21 21:14:22 CST 2025, time=2025-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2284113, encodeId=8b86228411378, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：按照审稿人给的修改意见认真修改后很快就被录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9fd6560658, createdName=ms6000000046559377, createdTime=Thu Oct 09 12:13:43 CST 2025, time=2025-10-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2262558, encodeId=fc282262558ae, content=JCR Q2，中科院医学大类3区，覆盖癌症生物学、免疫治疗、外科手术、基因组学等方向，尤其重视基础与临床研究的结合。期刊对国人友好，2022-2023年国人发文占比超56%，位居第一。 整体较快，平均1-3个月完成审稿。 文章类型：以Article（69.88%）和Review（24.69%）为主，病例报告需严格遵循CARE指南并获取患者知情同意。 格式要求：英语撰写，重复率≤10%，参考文献≥25条（近5年占比50%+），图表分辨率≥300dpi。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms6000002977722155, createdTime=Sun Apr 27 23:19:55 CST 2025, time=2025-04-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2260115, encodeId=d34e2260115b6, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤学 经验分享：2024年10月底投稿，外审大概2个月，修改一次后在2025年2月底就接收，2025年3月初发表，投稿的是一篇证据总结，我觉得还挺快的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d15e4714042, createdName=1442866843, createdTime=Sat Apr 12 09:46:11 CST 2025, time=2025-04-12, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2251961, encodeId=c36622519616a, content=偏重的研究方向：肿瘤 经验分享：第二次投了，妇科肿瘤方向，17天了仍是Editorial Assignment状态，副编辑仍未分配，朋友们你们的也这么慢吗？是杂志整体变慢了吗？我记得第一次的时候蛮快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c00d8129740, createdName=ms4000001757914888, createdTime=Fri Feb 14 19:13:46 CST 2025, time=2025-02-14, status=1, ipAttribution=辽宁), GetPortalCommentsPageByObjectIdResponse(id=2255948, encodeId=5ac5225594847, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：外科;结直肠癌 经验分享：结直肠癌外科手术方面的小文章，编辑速度很快，2个小修，2周修回，再1周接收。比较担心被预警。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/4oGJanAwYP71kBMib4MbsUH6DlDZThuRKQkJ1ibJkzuurhSJZ4zcxZPBQYr2OLZdl3dkfq351dJ9kWv5pCZmjLPg/132, createdBy=c2c22368859, createdName=prosperli, createdTime=Thu Mar 13 19:16:27 CST 2025, time=2025-03-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2252015, encodeId=9c2322520150a, content=偏重的研究方向：肿瘤 经验分享：投了一篇Meta，顺利接收，时间线如下： Received date: 16 Jan 2025 Editorial assignment start date: 16 Jan 2025 Independent review start date: 18 Jan 2025 Interactive review activated date: 26 Jan 2025 Review finalized date: 10 Feb 2025 Final validation date: 13 Feb 2025 感谢大家的经验分享，受益良多，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DSKSsTZWSAHzbu47LXNPxMa56rEEsmGbA6TZOLicSdqXhIJT8tce14ZrGYB0p0LPAKzZyVUUstj63e7UzvYT9ew/132, createdBy=1dff2428106, createdName=要没时间了, createdTime=Sat Feb 15 09:57:36 CST 2025, time=2025-02-15, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2247280, encodeId=86c0224e2800b, content=多久才能pubmed检索啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20b65452622, createdName=ms8000000124135786, createdTime=Thu Jan 09 14:13:27 CST 2025, time=2025-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2247822, encodeId=79ad224e82258, content=投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：审稿周期太长了，将近11个月，胃癌蛋白组学的分层模型，刚开始邀请2个审稿人，结果有一个给了provoke,再次邀请花费了将近3个月，最后1 1月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Mon Jan 13 01:43:01 CST 2025, time=2025-01-13, status=1, ipAttribution=山西省)]

2025-02-15 要没时间了来自辽宁省

偏重的研究方向：肿瘤
经验分享：投了一篇Meta，顺利接收，时间线如下： Received date: 16 Jan 2025 Editorial assignment start date: 16 Jan 2025 Independent review start date: 18 Jan 2025 Interactive review activated date: 26 Jan 2025 Review finalized date: 10 Feb 2025 Final validation date: 13 Feb 2025 感谢大家的经验分享，受益良多，谢谢

125 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2289815, encodeId=a3b4228981559, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：写的case，肿瘤病理分化特殊类型 8.26投稿，12.04号2个审稿小修修回，12.10接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuDC8KzEKjPbtibiazcGV6hymc4Fp1dg4xRJOicG9garJDkw2LxwsXJcB68P5Jrs2lTcVA2KMUpMAK3Z/0, createdBy=a5c62067526, createdName=ms4085869792928798, createdTime=Thu Nov 20 15:16:13 CST 2025, time=2025-11-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2266079, encodeId=9fba22660e938, content=请问有没有遇到版面费支付完后在invoice可以看到已支付，但是在submission还是显示unpaid，一般付款后几天能显示已支付呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=67dd2027216, createdName=1e227a5em69(暂无匿称), createdTime=Wed May 21 21:14:22 CST 2025, time=2025-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2284113, encodeId=8b86228411378, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：按照审稿人给的修改意见认真修改后很快就被录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9fd6560658, createdName=ms6000000046559377, createdTime=Thu Oct 09 12:13:43 CST 2025, time=2025-10-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2262558, encodeId=fc282262558ae, content=JCR Q2，中科院医学大类3区，覆盖癌症生物学、免疫治疗、外科手术、基因组学等方向，尤其重视基础与临床研究的结合。期刊对国人友好，2022-2023年国人发文占比超56%，位居第一。 整体较快，平均1-3个月完成审稿。 文章类型：以Article（69.88%）和Review（24.69%）为主，病例报告需严格遵循CARE指南并获取患者知情同意。 格式要求：英语撰写，重复率≤10%，参考文献≥25条（近5年占比50%+），图表分辨率≥300dpi。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms6000002977722155, createdTime=Sun Apr 27 23:19:55 CST 2025, time=2025-04-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2260115, encodeId=d34e2260115b6, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤学 经验分享：2024年10月底投稿，外审大概2个月，修改一次后在2025年2月底就接收，2025年3月初发表，投稿的是一篇证据总结，我觉得还挺快的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d15e4714042, createdName=1442866843, createdTime=Sat Apr 12 09:46:11 CST 2025, time=2025-04-12, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2251961, encodeId=c36622519616a, content=偏重的研究方向：肿瘤 经验分享：第二次投了，妇科肿瘤方向，17天了仍是Editorial Assignment状态，副编辑仍未分配，朋友们你们的也这么慢吗？是杂志整体变慢了吗？我记得第一次的时候蛮快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c00d8129740, createdName=ms4000001757914888, createdTime=Fri Feb 14 19:13:46 CST 2025, time=2025-02-14, status=1, ipAttribution=辽宁), GetPortalCommentsPageByObjectIdResponse(id=2255948, encodeId=5ac5225594847, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：外科;结直肠癌 经验分享：结直肠癌外科手术方面的小文章，编辑速度很快，2个小修，2周修回，再1周接收。比较担心被预警。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/4oGJanAwYP71kBMib4MbsUH6DlDZThuRKQkJ1ibJkzuurhSJZ4zcxZPBQYr2OLZdl3dkfq351dJ9kWv5pCZmjLPg/132, createdBy=c2c22368859, createdName=prosperli, createdTime=Thu Mar 13 19:16:27 CST 2025, time=2025-03-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2252015, encodeId=9c2322520150a, content=偏重的研究方向：肿瘤 经验分享：投了一篇Meta，顺利接收，时间线如下： Received date: 16 Jan 2025 Editorial assignment start date: 16 Jan 2025 Independent review start date: 18 Jan 2025 Interactive review activated date: 26 Jan 2025 Review finalized date: 10 Feb 2025 Final validation date: 13 Feb 2025 感谢大家的经验分享，受益良多，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DSKSsTZWSAHzbu47LXNPxMa56rEEsmGbA6TZOLicSdqXhIJT8tce14ZrGYB0p0LPAKzZyVUUstj63e7UzvYT9ew/132, createdBy=1dff2428106, createdName=要没时间了, createdTime=Sat Feb 15 09:57:36 CST 2025, time=2025-02-15, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2247280, encodeId=86c0224e2800b, content=多久才能pubmed检索啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20b65452622, createdName=ms8000000124135786, createdTime=Thu Jan 09 14:13:27 CST 2025, time=2025-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2247822, encodeId=79ad224e82258, content=投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：审稿周期太长了，将近11个月，胃癌蛋白组学的分层模型，刚开始邀请2个审稿人，结果有一个给了provoke,再次邀请花费了将近3个月，最后1 1月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Mon Jan 13 01:43:01 CST 2025, time=2025-01-13, status=1, ipAttribution=山西省)]

2025-01-09 ms8000000124135786

多久才能pubmed检索啊

140 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2289815, encodeId=a3b4228981559, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：写的case，肿瘤病理分化特殊类型 8.26投稿，12.04号2个审稿小修修回，12.10接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuDC8KzEKjPbtibiazcGV6hymc4Fp1dg4xRJOicG9garJDkw2LxwsXJcB68P5Jrs2lTcVA2KMUpMAK3Z/0, createdBy=a5c62067526, createdName=ms4085869792928798, createdTime=Thu Nov 20 15:16:13 CST 2025, time=2025-11-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2266079, encodeId=9fba22660e938, content=请问有没有遇到版面费支付完后在invoice可以看到已支付，但是在submission还是显示unpaid，一般付款后几天能显示已支付呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=67dd2027216, createdName=1e227a5em69(暂无匿称), createdTime=Wed May 21 21:14:22 CST 2025, time=2025-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2284113, encodeId=8b86228411378, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：按照审稿人给的修改意见认真修改后很快就被录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9fd6560658, createdName=ms6000000046559377, createdTime=Thu Oct 09 12:13:43 CST 2025, time=2025-10-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2262558, encodeId=fc282262558ae, content=JCR Q2，中科院医学大类3区，覆盖癌症生物学、免疫治疗、外科手术、基因组学等方向，尤其重视基础与临床研究的结合。期刊对国人友好，2022-2023年国人发文占比超56%，位居第一。 整体较快，平均1-3个月完成审稿。 文章类型：以Article（69.88%）和Review（24.69%）为主，病例报告需严格遵循CARE指南并获取患者知情同意。 格式要求：英语撰写，重复率≤10%，参考文献≥25条（近5年占比50%+），图表分辨率≥300dpi。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms6000002977722155, createdTime=Sun Apr 27 23:19:55 CST 2025, time=2025-04-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2260115, encodeId=d34e2260115b6, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤学 经验分享：2024年10月底投稿，外审大概2个月，修改一次后在2025年2月底就接收，2025年3月初发表，投稿的是一篇证据总结，我觉得还挺快的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d15e4714042, createdName=1442866843, createdTime=Sat Apr 12 09:46:11 CST 2025, time=2025-04-12, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2251961, encodeId=c36622519616a, content=偏重的研究方向：肿瘤 经验分享：第二次投了，妇科肿瘤方向，17天了仍是Editorial Assignment状态，副编辑仍未分配，朋友们你们的也这么慢吗？是杂志整体变慢了吗？我记得第一次的时候蛮快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c00d8129740, createdName=ms4000001757914888, createdTime=Fri Feb 14 19:13:46 CST 2025, time=2025-02-14, status=1, ipAttribution=辽宁), GetPortalCommentsPageByObjectIdResponse(id=2255948, encodeId=5ac5225594847, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：外科;结直肠癌 经验分享：结直肠癌外科手术方面的小文章，编辑速度很快，2个小修，2周修回，再1周接收。比较担心被预警。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/4oGJanAwYP71kBMib4MbsUH6DlDZThuRKQkJ1ibJkzuurhSJZ4zcxZPBQYr2OLZdl3dkfq351dJ9kWv5pCZmjLPg/132, createdBy=c2c22368859, createdName=prosperli, createdTime=Thu Mar 13 19:16:27 CST 2025, time=2025-03-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2252015, encodeId=9c2322520150a, content=偏重的研究方向：肿瘤 经验分享：投了一篇Meta，顺利接收，时间线如下： Received date: 16 Jan 2025 Editorial assignment start date: 16 Jan 2025 Independent review start date: 18 Jan 2025 Interactive review activated date: 26 Jan 2025 Review finalized date: 10 Feb 2025 Final validation date: 13 Feb 2025 感谢大家的经验分享，受益良多，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DSKSsTZWSAHzbu47LXNPxMa56rEEsmGbA6TZOLicSdqXhIJT8tce14ZrGYB0p0LPAKzZyVUUstj63e7UzvYT9ew/132, createdBy=1dff2428106, createdName=要没时间了, createdTime=Sat Feb 15 09:57:36 CST 2025, time=2025-02-15, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2247280, encodeId=86c0224e2800b, content=多久才能pubmed检索啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20b65452622, createdName=ms8000000124135786, createdTime=Thu Jan 09 14:13:27 CST 2025, time=2025-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2247822, encodeId=79ad224e82258, content=投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：审稿周期太长了，将近11个月，胃癌蛋白组学的分层模型，刚开始邀请2个审稿人，结果有一个给了provoke,再次邀请花费了将近3个月，最后1 1月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Mon Jan 13 01:43:01 CST 2025, time=2025-01-13, status=1, ipAttribution=山西省)]

2025-01-13 shademei 来自山西省

投稿命中率:50.0
偏重的研究方向：肿瘤
经验分享：审稿周期太长了，将近11个月，胃癌蛋白组学的分层模型，刚开始邀请2个审稿人，结果有一个给了provoke,再次邀请花费了将近3个月，最后1 1月接受

127 0 举报

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务